R Gary Hollenbeck is a prominent inventor based in Ellicott City, MD, USA, known for his significant contributions to the field of pharmaceutical technology. With a remarkable portfolio of 7 patents, Hollenbeck has dedicated his career to developing innovative solutions focusing on drug delivery systems.

Latest Patents

Among his notable inventions, Hollenbeck holds patents for methods and compositions aimed at the self-regulated release of active pharmaceutical ingredients. His latest patent revolves around an abuse deterrent pharmaceutical composition that includes a pharmaceutically active ingredient, an acid-soluble ingredient, and a buffering ingredient. This formulation is designed to retard the release of the active ingredient when consumed in excess of its intended dosage, providing a groundbreaking approach to addressing substance misuse.

Career Highlights

Hollenbeck's career includes pivotal roles in well-known companies like Acura Pharmaceuticals and Abuse Deterrent Pharmaceuticals. His work has focused on creating safer pharmaceutical formulations that can mitigate potential abuse, showcasing his commitment to enhancing patient safety through innovation.

Collaborations

Throughout his career, Hollenbeck has collaborated with various professionals, including his coworker Albert W Brzeczko. These collaborations have played a vital role in advancing his research and fostering a culture of innovation within the pharmaceutical industry.

Conclusion

R Gary Hollenbeck's contributions to pharmaceutical technology represent a critical advancement in the fight against prescription drug abuse. His dedication to developing self-regulated drug release systems not only underscores his inventive spirit but also highlights the importance of innovation in improving health outcomes. The legacy of his work continues to impact the pharmaceutical landscape significantly, paving the way for safer medication practices.

This text is generated by artificial intelligence and may not be accurate.